{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:26:51Z","timestamp":1793600811821,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305697\/2023\\u20134"],"award-info":[{"award-number":["305697\/2023\\u20134"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005670","name":"FAPERN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Finep","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011875","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia, Inova\u00e7\u00f5es e Comunica\u00e7\u00f5es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008532","name":"Universidade Federal do Rio Grande do Norte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008532","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neuropharm.2026.110947","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:08:52Z","timestamp":1774310932000},"page":"110947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4645-8389","authenticated-orcid":false,"given":"Anne Nathalia","family":"de Sousa-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6186-2526","authenticated-orcid":false,"given":"Clarissa de Almeida","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4764-9029","authenticated-orcid":false,"given":"Carina Ion\u00e1","family":"de Oliveira Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7069-5041","authenticated-orcid":false,"given":"Vit\u00f3ria Barros","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayane M.","family":"do Nascimento Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lob\u00e3o-Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Ruschi Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Galv\u00e3o-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Palhano-Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Draulio Barros de","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5505-8056","authenticated-orcid":false,"suffix":"Jr.","given":"Edilson Dantas","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-1369","authenticated-orcid":false,"given":"Elaine C.","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0278-5846(85)90074-0","article-title":"Effects of DOM and DMT in a proposed animal model of hallucinogenic activity","volume":"9","author":"Adams","year":"1985","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110947_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders [DSM-V]","year":"2022"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/diagnostics11010123","article-title":"Animal models of depression: what can they teach Us about the human disease?","volume":"11","author":"Becker","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110947_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014","article-title":"Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity","volume":"76","author":"Belujon","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110947_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/mp.2011.47","article-title":"Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice","volume":"16","author":"Beurel","year":"2011","journal-title":"Mol. Psychiatr."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.110947_bib6","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm000339w","article-title":"Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines","volume":"43","author":"Blair","year":"2000","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110947_bib7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/jm980692q","article-title":"Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine","volume":"42","author":"Blair","year":"1999","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s12035-021-02614-4","article-title":"Systematic input-output mapping reveals structural plasticity of VTA dopamine Neurons-Zona Incerta Loop underlying the social buffering effects in learned helplessness","volume":"59","author":"Cai","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110947_bib9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-Dimethyltryptamine on rat behaviors relevant to anxiety and depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110947_bib10","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N,N-Dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2026.110947_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.110947_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib13","first-page":"199","article-title":"Effect of fluvoxamine and N-methyl-D-aspartate receptor antagonists on shock-induced depression in mice","volume":"45","author":"Chaturvedi","year":"2001","journal-title":"Indian J. Physiol. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110947_bib14","first-page":"952","article-title":"Interaction between N-methyl-D-aspartate receptor antagonists and imipramine in shock-induced depression","volume":"37","author":"Chaturvedi","year":"1999","journal-title":"Indian J. Exp. Biol."},{"issue":"1-3","key":"10.1016\/j.neuropharm.2026.110947_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresprot.2005.09.002","article-title":"Learned helplessness: validity and reliability of depressive-like states in mice","volume":"16","author":"Chourbaji","year":"2005","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.neuropharm.2026.110947_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2019.00104","article-title":"Dissociation in effective treatment and behavioral phenotype between stress-enhanced fear learning and learned helplessness","volume":"13","author":"Conoscenti","year":"2019","journal-title":"Front. Behav. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110947_bib17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/dta.2889","article-title":"Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials","volume":"12","author":"Cozzi","year":"2020","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110947_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/sj.npp.1301533","article-title":"Females do not express learned helplessness like males do","volume":"33","author":"Dalla","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110947_bib79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11011-025-01650-6","article-title":"Immunomodulatory and behavioral effects of ayahuasca and N, N-dimethyltryptamine in a rat model of lipopolysaccharide-induced depression","volume":"40","author":"do Nascimento Sousa","year":"2025","journal-title":"Metab Brain Dis."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110947_bib20","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41386-022-01344-y","article-title":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","volume":"47","author":"D'Souza","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110947_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental health: preclinical and clinical studies on LSD, Psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/psymed.2024.0002","article-title":"The antidepressant effects of vaporized N,N-Dimethyltryptamine: an open-label pilot trial in treatment-resistant depression","volume":"3","author":"Falchi-Carvalho","year":"2025","journal-title":"Psychedelic Med. (New Rochelle)"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110947_bib24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41386-025-02091-6","article-title":"Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression","volume":"50","author":"Falchi-Carvalho","year":"2025","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-Ketamine in rodent models: Comparison with (S)-Ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-020-05719-1","article-title":"Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants","volume":"238","author":"Galv\u00e3o-Coelho","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00491975","article-title":"A characteristic effect of hallucinogens on investigatory responding in rats","volume":"65","author":"Geyer","year":"1979","journal-title":"Psychopharmacology (Berl)."},{"issue":"10440","key":"10.1016\/j.neuropharm.2026.110947_bib28","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.110947_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.microc.2012.03.033","article-title":"Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks","volume":"109","author":"Gaujac","year":"2013","journal-title":"Microchem. J."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110947_bib30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110947_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110947_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainresbull.2021.11.005","article-title":"Tamsulosin facilitates depressive-like behaviors in mice: involvement of endogenous glucocorticoids","volume":"178","author":"Holanda","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110947_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jphs.2017.11.001","article-title":"Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine","volume":"135","author":"Ide","year":"2017","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13041-015-0153-7","article-title":"PARP-1 activity is required for the reconsolidation and extinction of contextual fear memory","volume":"8","author":"Inaba","year":"2015","journal-title":"Mol. Brain"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110947_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jamapsychiatry.2025.1317","article-title":"Esketamine monotherapy in adults with treatment-resistant depression: a randomized clinical trial","volume":"82","author":"Janik","year":"2025","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0269881120959644","article-title":"Ketamine: a tale of two enantiomers","volume":"35","author":"Jelen","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110947_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/ph15101203","article-title":"Monoamine neurotransmitters control basic emotions and affect major depressive disorders","volume":"15","author":"Jiang","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2026.110947_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"7932","key":"10.1016\/j.neuropharm.2026.110947_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","article-title":"Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity","volume":"610","author":"Kaplan","year":"2022","journal-title":"Nature"},{"issue":"7270","key":"10.1016\/j.neuropharm.2026.110947_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.110947_bib41","first-page":"3","article-title":"Whole-Brain mapping of neuronal activity in the learned helplessness model of depression","volume":"10","author":"Kim","year":"2016","journal-title":"Front. Neural Circ."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110947_bib43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.pnpbp.2007.05.002","article-title":"Effect of various classes of antidepressants in behavioral paradigms of despair","volume":"31","author":"Kulkarni","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110947_bib44","doi-asserted-by":"crossref","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 20100;329(5994):959-964. doi: 10.1126\/science.1190287.","DOI":"10.1126\/science.1190287"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41398-026-03852-7","article-title":"Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model","volume":"16","author":"Lima da Cruz","year":"2026","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology (Berl)."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110947_bib47","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110947_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","article-title":"Major depressive disorder","volume":"9","author":"Marx","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110947_bib50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110947_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","article-title":"Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes","volume":"29","author":"McKenna","year":"1990","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110947_bib52","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/brainsci14121291","article-title":"Ketamine reduces avoidance responses during Re-Exposition to aversive stimulus: Comparison between (S)-Isomer and racemic mixture","volume":"14","author":"Moura","year":"2024","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110947_bib54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14740338.2022.2066651","article-title":"Long-term safety of ketamine and esketamine in treatment of depression","volume":"21","author":"Nikayin","year":"2022","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.neuropharm.2026.110947_bib55","author":"Pantrigo","year":"2024"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110947_bib56","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1016\/j.bmc.2008.02.033","article-title":"The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands","volume":"16","author":"Parker","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00443425","article-title":"Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex","volume":"97","author":"Pierce","year":"1989","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2026.110947_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112153","article-title":"Rodent ketamine depression-related research: finding patterns in a literature of variability","volume":"376","author":"Polis","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.110947_bib59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.euroneuro.2023.08.496","article-title":"Sucrose preference test: a systematic review of protocols for the assessment of anhedonia in rodents","volume":"77","author":"Primo","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR\u2217D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.neuropharm.2026.110947_bib61","first-page":"107","article-title":"Novelty-Suppressed feeding in the mouse","volume":"vol. 63","author":"Samuels","year":"2011"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110947_bib62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.fbp.0000171772.61669.6f","article-title":"Reduced sensitivity to sucrose in rats bred for helplessness: a study using the matching law","volume":"16","author":"Sanchis-Segura","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110947_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2017.08.026","article-title":"Ketamine promotes increased freezing behavior in rats with experimental PTSD without changing brain glucose metabolism or BDNF","volume":"658","author":"Saur","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"16","key":"10.1016\/j.neuropharm.2026.110947_bib64","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110947_bib65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.neuropharm.2026.110947_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111419","article-title":"Safety and tolerability of NN-dimethyltryptamine (DMT) in healthy volunteers and Major Depressive Disorder (MDD) patients: a systematic review of early-phase clinical trials","volume":"140","author":"Swieczkowski","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib67","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/psymed.2023.0010","article-title":"Learned helplessness as a potential transdiagnostic therapeutic mechanism of classic psychedelics","volume":"1","author":"Tiwari","year":"2023","journal-title":"Psychedelic Med. (New Rochelle)"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110947_bib68","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s12031-022-01982-3","article-title":"The effect of Sericin on the cognitive impairment, depression, and anxiety caused by learned helplessness in Male mice","volume":"72","author":"Vatandoust","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110947_bib69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cpt.3478","article-title":"Ketamine and esketamine in clinical trials: FDA-Approved and emerging indications, trial trends with putative mechanistic explanations","volume":"117","author":"Vekhova","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib70","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00441-013-1654-2","article-title":"Learned helplessness: unique features and translational value of a cognitive depression model","volume":"354","author":"Vollmayr","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2026.110947_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105899","article-title":"Psychedelics: a review of their effects on recalled aversive memories and fear\/anxiety expression in rodents","volume":"167","author":"Werle","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110947_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110947_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4747449","article-title":"Global, regional, and national epidemiology of depression in working-age individuals, 1990-2019","volume":"2024","author":"Yang","year":"2024","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","article-title":"Ketamine treatment for depression: a review","volume":"2","author":"Yavi","year":"2022","journal-title":"Discov. Ment. Health"},{"issue":"7604","key":"10.1016\/j.neuropharm.2026.110947_bib75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110947_bib76","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110947_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(92)90248-3","article-title":"Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons","volume":"213","author":"Zeilhofer","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110947_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:33:06Z","timestamp":1793597586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":79,"alternative-id":["S0028390826001206"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110947","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110947"}}